---
figid: PMC8881512__41467_2022_28691_Fig7_HTML
figtitle: The Hippo-YAP-VGLL3 axis in the regulation of ESR1 expression and ER+ BRCA
  growth
organisms:
- Adenoviridae
- Adeno-associated virus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Lareunionomyces loeiensis
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8881512
filename: 41467_2022_28691_Fig7_HTML.jpg
figlink: /pmc/articles/PMC8881512/figure/Fig7/
number: F7
caption: A proposed model for ERα regulation by Hippo-YAP via VGLL3 and NCOR2. Pharmacological
  targeting of LATS with kinase inhibitor VT02956 or VGLL3 induction with benzamide
  derivative histone deacetylase (HDAC) inhibitors suppresses ERα dependent tumour
  growth.
papertitle: Transcriptional repression of estrogen receptor alpha by YAP reveals the
  Hippo pathway as therapeutic target for ER+ breast cancer.
reftext: Shenghong Ma, et al. Nat Commun. 2022;13:1061.
year: '2022'
doi: 10.1038/s41467-022-28691-0
journal_title: Nature Communications
journal_nlm_ta: Nat Commun
publisher_name: Nature Publishing Group UK
keywords: Breast cancer | HIPPO signalling | High-throughput screening
automl_pathway: 0.9560641
figid_alias: PMC8881512__F7
figtype: Figure
redirect_from: /figures/PMC8881512__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8881512__41467_2022_28691_Fig7_HTML.html
  '@type': Dataset
  description: A proposed model for ERα regulation by Hippo-YAP via VGLL3 and NCOR2.
    Pharmacological targeting of LATS with kinase inhibitor VT02956 or VGLL3 induction
    with benzamide derivative histone deacetylase (HDAC) inhibitors suppresses ERα
    dependent tumour growth.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - wts
  - yki
  - sd
  - HDAC4
  - HDAC6
  - HDAC1
  - HDAC3
  - era
---
